- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - hetero-3-3-3-mer
 - Ligands
 - 20 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 30 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 NAG.22: 1 residues within 4Å:- Chain C: N.657
 
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain C: N.616, T.618
 
Ligand excluded by PLIPNAG.24: 1 residues within 4Å:- Chain C: N.603
 
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain C: E.132, N.164, N.165
 
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain C: Y.28, N.61
 
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain C: N.280, E.281, N.282
 
Ligand excluded by PLIPNAG.28: 4 residues within 4Å:- Chain C: N.122, A.123, N.125, V.127
 
Ligand excluded by PLIPNAG.29: 5 residues within 4Å:- Chain C: A.706, E.1072, K.1073, N.1074
 - Ligands: NAG.30
 
Ligand excluded by PLIPNAG.30: 6 residues within 4Å:- Chain C: N.1074, F.1075, T.1076, S.1097, N.1098
 - Ligands: NAG.29
 
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain D: H.655, N.657
 
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain D: N.616, T.618, Q.644
 
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain D: N.603
 
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain D: E.132, N.164, N.165
 
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain D: Y.28, N.30, N.61
 
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain D: N.282, T.284
 
Ligand excluded by PLIPNAG.37: 4 residues within 4Å:- Chain D: N.122, A.123, N.125, K.129
 
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain D: N.331, Q.580
 
Ligand excluded by PLIPNAG.39: 6 residues within 4Å:- Chain D: A.706, E.1072, K.1073, N.1074
 - Chain G: Q.895
 - Ligands: NAG.40
 
Ligand excluded by PLIPNAG.40: 4 residues within 4Å:- Chain D: N.1074, T.1076, N.1098
 - Ligands: NAG.39
 
Ligand excluded by PLIPNAG.41: 1 residues within 4Å:- Chain D: N.234
 
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain D: K.558
 - Chain G: N.280, N.282
 
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain G: N.657
 
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain G: N.616, T.618
 
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain G: N.603
 
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain G: E.132, N.164, N.165
 
Ligand excluded by PLIPNAG.47: 3 residues within 4Å:- Chain G: Y.28, F.59, N.61
 
Ligand excluded by PLIPNAG.48: 4 residues within 4Å:- Chain G: N.122, A.123, N.125, V.127
 
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain G: N.331, Q.580, T.581
 
Ligand excluded by PLIPNAG.50: 5 residues within 4Å:- Chain C: Q.895
 - Chain G: A.706, S.711, N.1074
 - Ligands: NAG.51
 
Ligand excluded by PLIPNAG.51: 4 residues within 4Å:- Chain G: N.1074, F.1075, T.1076
 - Ligands: NAG.50
 
Ligand excluded by PLIP- Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Peng, L. et al., Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617. Nat Commun (2022)
          


 - Release Date
 - 2022-03-16
 - Peptides
 - Fab of antibody clone 6, light chain: AEH
Fab of antibody clone 6, heavy chain: BFI
Spike glycoprotein: CDG - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
LE
GH
EB
HF
FI
DC
CD
BG
A 
- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - hetero-3-3-3-mer
 - Ligands
 - 20 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 30 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Peng, L. et al., Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617. Nat Commun (2022)
          


 - Release Date
 - 2022-03-16
 - Peptides
 - Fab of antibody clone 6, light chain: AEH
Fab of antibody clone 6, heavy chain: BFI
Spike glycoprotein: CDG - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
LE
GH
EB
HF
FI
DC
CD
BG
A